TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Arrakis Therapeutics Stock

Arrakis Therapeutics Stock

arrakistx.comHealthcareFounded: 2015Funding to Date: $113.5MM

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA.

Buy or sell Arrakis Therapeutics stockLearn more about Arrakis Therapeutics IPO
Register for Details

For more details on financing and valuation for Arrakis Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Arrakis Therapeutics.

Register Today

Team

Management Team

Daniel Koerwer
Chief Business Officer
Heather Lounsbury
Vice President of Business & Technical Operations
Jennifer Petter Ph.D
Co-Founder & Chief Scientific Officer
Rajesh Parekh Ph.D
Co-Founder & Board Member
Michael Gilman Ph.D
Chief Executive Officer & Chairman
Alan Walts Ph.D
Co-Founder & Board Member
James Barsoum Ph.D
Senior Vice President of Biology
Henri Termeer
Co-Founder

Board Members

Carolyn Green
Matthew Cohen Ph.D
Osage Venture Partners
Rajesh Parekh Ph.D
Alan Walts Ph.D
Jakob Loven Ph.D
Nextech Invest
Nikola Trbovic Ph.D
Pfizer Ventures
Colleen Cuffaro Ph.D
Canaan Partners
Elaine Jones Ph.D
Pfizer Ventures
Peter Worland Ph.D
Celgene
Richard Gaster MD
venBio
Michael Gilman Ph.D
Timothy Shannon MD
Canaan Partners

Other companies like Arrakis Therapeutics in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Paradromics
Sector
Healthcare
 
 
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B

News

Market Screener 11/21/2019
Arrakis Therapeutics : Appoints Katrine Bosley as Chairman of the Board of Directors
Business Wire 11/19/2019
Arrakis Therapeutics Appoints Elizabeth Radcliffe as Vice President of Finance and Strategy
Arrakis Therapeutics appoints Elizabeth Radcliffe as Vice President of Finance and Strategy.

Trending Companies

Frequently Asked Questions

Updated on: Jun 3, 2023